Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry

References

• Guo J, Rapoport B, McLachlan. Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro. Autoimmunity 1999; 30: 1–9
   PubMed Web of Science ®Google Scholar
• Bossowski A, Urban M, Sobotko J. Detection of chosen cytokines (IL-6, sIL-6R, IL-8, IL-12, IL-15) in young patients with Graves' disease treated by methimazole. Pol Endocrinol 2000; 4: 519–538
   Google Scholar
• Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K. Maturation of thyroidal dendritic cells in Graves' disease. Scand J Immunol 2002; 55: 612–620
   PubMedGoogle Scholar
• McLachan S, Rapoport B. Autoimmune response to the thyroid in human: Thyroid peroxidase—the common autoantigenic denominator. Int Rev Immunol 2000; 19: 587–618
   PubMedGoogle Scholar
• Czarnocka B, Ruf J, Ferrand M, Lissitzky S, Carayon P. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 147–152
   PubMed Web of Science ®Google Scholar
• McLachan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in thyroid disease. Endocr Rev 1992; 13: 192–206
   PubMedGoogle Scholar
• Weetman AP, McGregor AM. Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 1994; 15: 788–830
   PubMed Web of Science ®Google Scholar
• Ruf J, Toubert MJ, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P. Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 1989; 125: 1211–1218
   PubMed Web of Science ®Google Scholar
• Czarnocka B, Pastuszko D, Carayon P, Ruf J, Gardas A. Majority of thyroid peroxidase autoantibodies in patients with autoimmune thyroid disease are directed to single TPO domain. Autoimmunity 1996; 23: 145–154
   PubMed Web of Science ®Google Scholar
• Janota-Bzowski M, Czarnocka B, McIntosh RS, Asghar MS, Watson PF, Kemp EH, Pastuszko D, Łyczkowska A, Carayon P, Wetman AP. Comparison of immunodominant regions of TPO defined by murine anti-human TPO monoclonal antibodies and recombinant anti-TPO IgG (Fab fragments from patients with Hashimoto's thyroiditis. Pol Endocrinol 1997; 48: 237–247
   Google Scholar
• Rasmussen AK, Feldt-Rasmussn U, Brandt M, Hartoft-Nielsen ML, Carayon P, Buschard K. Thyrotropin stimulates specifically the expression of the autoantibody binding domains of the thyroperoxidase molecule. Autoimmunity 1998; 29: 323–331
   Google Scholar
• Ajjan RA, Kemp EH, Waterman EA, Watson PF, Endo T, Onaya T, Weetman AP. Detection of binding and blocking autoantibodies to the human sodium-iodine symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 2020–2027
   PubMedGoogle Scholar
• Akamizu T, Moriyama K, Miura M, Saijo M, Matsuda F, Nakao K. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: Epitope and binding study of two stimulatory TSHRAbs. Endocrinology 1999; 140: 1594–1601
   PubMed Web of Science ®Google Scholar
• Wallaschofski H, Paschke R. Detection of thyroid stimulating (TSAB) and thyrotrpoin stimulation blocking (TSBAB) antibodies with CHO cell lines expresssing different TSH-receptor numbers. Clin Endocrinol 1999; 50: 365–372
   PubMedGoogle Scholar
• Bolton J, Sanders J, Oda Y, Champan C, Konno R, Furmaniak J. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 1999; 45: 2285–2287
   PubMed Web of Science ®Google Scholar
• Kakinuma A, Morimoto I, Kuroda T, Fujihira T. Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies. Thyroid 1999; 9: 849–855
   PubMedGoogle Scholar
• Eguchi K, Matsuoka N, Nagatki S. Cellular immunity in autoimmune thyroid disease. Bailliere's Clin Endocrinol Metab 1995; 9: 71–94
   PubMedGoogle Scholar
• Pozzilli P, Carotenuto P, Delitalia G. Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity. Clin Endocrinol 1994; 41: 545–554
   PubMed Web of Science ®Google Scholar
• Marazuela M. Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur J Endocrinol 1999; 140: 287–290
   PubMedGoogle Scholar
• Bossowski A, Urban M, Stasiak-Barmuta A. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metabol 2003; 16: 1–9
   Google Scholar
• Bossowski A, Urban M, Stasiak-Barmuta A. Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease. Pediatr Res 2003; 54: 425–429
   PubMedGoogle Scholar
• Czarnocka B, Janota-Bzowski M, McIntosh RS, Asghar MS, Watson PF, Kemp EH, Carayon P, Weetman P. Immunoglobulin Gκ antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope—mapping analysis. J Clin Endocrinol Metabol 1997; 82: 2639–2644
   PubMed Web of Science ®Google Scholar
• Hashizum K, Ichikawa K, Sakurai A, Suzuki S, Takeda M, Kobayashi M, Miyamoto T, Arai M, Nagasawa T. Administration of thyroxine in treated Graves' disease—effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. New Engl J Med 1991; 324: 947–953
   PubMedGoogle Scholar
• Buschard K, Brogren CH, Ropke C, Rygaard J. Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2. APMIS 1988; 96: 342–346
   PubMed Web of Science ®Google Scholar